Menü
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Merck's Stock Dip Offers a Buying Opportunity: Here’s Why: https://www.marketbeat.com/logos/articles/med_20240819101736_chartb-mrk.jpg
Merck's Stock Dip Offers a Buying Opportunity: Here’s Why

Global big pharmaceutical company Merck & Co. Inc. (NYSE: MRK) shares sank 9% following its Q2 2024 earnings release. Merck beat top and bottom line estimates, but the lowered full-year EPS 2024

3 Stocks with Surging Call Option Volume in the Recovery Rally: https://www.marketbeat.com/logos/articles/med_20240819134752_3-stocks-with-surging-call-option-volume-in-the-re.jpg
3 Stocks with Surging Call Option Volume in the Recovery Rally

When investors seek exposure to the stocks of their choice, they typically take a one-dimensional approach to taking on risk to enjoy the potential upside in their views. Participants will buy

3 Stocks with Surging Call Option Volume in the Recovery Rally: https://www.marketbeat.com/logos/articles/med_20240819134752_3-stocks-with-surging-call-option-volume-in-the-re.jpg
3 Stocks with Surging Call Option Volume in the Recovery Rally

When investors seek exposure to the stocks of their choice, they typically take a one-dimensional approach to taking on risk to enjoy the potential upside in their views. Participants will buy

3 High P/E Stocks That Are Still Worth Buying Right Now: https://www.marketbeat.com/logos/articles/med_20240819134053_3-high-pe-stocks-that-are-still-worth-buying-right.jpg
3 High P/E Stocks That Are Still Worth Buying Right Now

One of the most common fundamental metrics that investors use to analyze stocks is the price-to-earnings (P/E) ratio. This ratio tells you how much you’re paying for $1 of a company’s profits. The

3 High P/E Stocks That Are Still Worth Buying Right Now: https://www.marketbeat.com/logos/articles/med_20240819134053_3-high-pe-stocks-that-are-still-worth-buying-right.jpg
3 High P/E Stocks That Are Still Worth Buying Right Now

One of the most common fundamental metrics that investors use to analyze stocks is the price-to-earnings (P/E) ratio. This ratio tells you how much you’re paying for $1 of a company’s profits. The

3 High P/E Stocks That Are Still Worth Buying Right Now: https://www.marketbeat.com/logos/articles/med_20240819134053_3-high-pe-stocks-that-are-still-worth-buying-right.jpg
3 High P/E Stocks That Are Still Worth Buying Right Now

One of the most common fundamental metrics that investors use to analyze stocks is the price-to-earnings (P/E) ratio. This ratio tells you how much you’re paying for $1 of a company’s profits. The

Why Traders Are Betting Big on Gold and Defense Stocks Now: https://www.marketbeat.com/logos/articles/med_20240819125952_why-traders-are-betting-big-on-gold-and-defense-st.jpg
Why Traders Are Betting Big on Gold and Defense Stocks Now

Investors can find out where the market’s attention is headed in the near future through proper tools like volume scanners or options contracts filters. Recently, three stocks connected the dots

Decoding Jackson Hole: The Fed's Impact on Your Stock Portfolio: https://www.marketbeat.com/logos/articles/med_20240819113159_decoding-jackson-hole-the-feds-impact-on-your-stoc.jpg
Decoding Jackson Hole: The Fed's Impact on Your Stock Portfolio

The financial world is holding its breath as the annual Jackson Hole Economic Symposium takes center stage, with Federal Reserve Chair Jerome Powell's highly anticipated speech on Friday morning

Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?: https://www.marketbeat.com/logos/articles/med_20240818191248_chartb-mrna.jpg
Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?

Biotechnology company Moderna Inc. (NASDAQ: MRNA) stock rocked investors with a 30% drop following its second-quarter 2024 earnings release. The company disappointed investors when it revised

Lululemon Stock Gears Up for a Massive Comeback Rally: https://www.marketbeat.com/logos/articles/med_20240819095302_lululemon-stock-gears-up-for-a-massive-comeback-ra.jpg
Lululemon Stock Gears Up for a Massive Comeback Rally

For a stock that once rallied hand-in-hand with tech stocks, even though it’s essentially a fashion brand, Lululemon Athletica Inc’s (NASDAQ: LULU) current fall from grace must be a tough one

Lululemon Stock Gears Up for a Massive Comeback Rally: https://www.marketbeat.com/logos/articles/med_20240819095302_lululemon-stock-gears-up-for-a-massive-comeback-ra.jpg
Lululemon Stock Gears Up for a Massive Comeback Rally

For a stock that once rallied hand-in-hand with tech stocks, even though it’s essentially a fashion brand, Lululemon Athletica Inc’s (NASDAQ: LULU) current fall from grace must be a tough one

This Early-Stage Biotech Stock Is Up 400% — Should You Buy Now?: https://www.marketbeat.com/logos/articles/med_20240816144216_this-early-stage-biotech-stock-is-up-400-should-yo.jpg
This Early-Stage Biotech Stock Is Up 400% — Should You Buy Now?

Avidity Biosciences (NASDAQ: RNA) is a biopharmaceutical stock focusing on RNA therapeutics. The company’s stock is up around 400% so far in 2024.

However, even with this massive appreciation

Microvast vs. FREYR: Which Battery Stock Holds the Power?: https://www.marketbeat.com/logos/articles/med_20240816134908_microvast-vs.jpg
Microvast vs. FREYR: Which Battery Stock Holds the Power?

In 2021, the term SPAC became part of the investor’s dictionary. SPAC stands for special purpose acquisition company, and it was a way many companies went public in 2020 and 2021. Many of those

Retail Earnings: Value, Caution, and Luxury in a Shifting Market: https://www.marketbeat.com/logos/articles/med_20240816133631_retail-earnings-value-caution-and-luxury-in-a-shif.jpg
Retail Earnings: Value, Caution, and Luxury in a Shifting Market

Retail sector earnings season is about more than the statistics and metrics of your favorite retail brand. It's a window into the evolving dynamics of consumer behavior and the economic forces

Retail Earnings: Value, Caution, and Luxury in a Shifting Market: https://www.marketbeat.com/logos/articles/med_20240816133631_retail-earnings-value-caution-and-luxury-in-a-shif.jpg
Retail Earnings: Value, Caution, and Luxury in a Shifting Market

Retail sector earnings season is about more than the statistics and metrics of your favorite retail brand. It's a window into the evolving dynamics of consumer behavior and the economic forces

Is YETI Stock an Outlier or a Sign of a Strong Brand?: https://www.marketbeat.com/logos/articles/med_20240816131337_is-yeti-stock-an-outlier-or-a-sign-of-a-strong-bra.jpg
Is YETI Stock an Outlier or a Sign of a Strong Brand?

Earnings season is always good for a few surprises. One name that's surprising to the upside is YETI Holdings Inc. (NYSE: YETI). The company, which makes iconic coolers and focuses on those who

Is YETI Stock an Outlier or a Sign of a Strong Brand?: https://www.marketbeat.com/logos/articles/med_20240816131337_is-yeti-stock-an-outlier-or-a-sign-of-a-strong-bra.jpg
Is YETI Stock an Outlier or a Sign of a Strong Brand?

Earnings season is always good for a few surprises. One name that's surprising to the upside is YETI Holdings Inc. (NYSE: YETI). The company, which makes iconic coolers and focuses on those who

The Worst May Be Over for Cisco After Beating Estimates in Q4: https://www.marketbeat.com/logos/articles/med_20240816085900_the-worst-may-be-over-for-cisco-after-beating-esti.jpg
The Worst May Be Over for Cisco After Beating Estimates in Q4

Cisco Systems (NASDAQ: CSCO) is a U.S. technology firm and is the world’s largest company in the communications equipment industry. Shares have seen significant underperformance compared to its

The Worst May Be Over for Cisco After Beating Estimates in Q4: https://www.marketbeat.com/logos/articles/med_20240816085900_the-worst-may-be-over-for-cisco-after-beating-esti.jpg
The Worst May Be Over for Cisco After Beating Estimates in Q4

Cisco Systems (NASDAQ: CSCO) is a U.S. technology firm and is the world’s largest company in the communications equipment industry. Shares have seen significant underperformance compared to its

The Worst May Be Over for Cisco After Beating Estimates in Q4: https://www.marketbeat.com/logos/articles/med_20240816085900_the-worst-may-be-over-for-cisco-after-beating-esti.jpg
The Worst May Be Over for Cisco After Beating Estimates in Q4

Cisco Systems (NASDAQ: CSCO) is a U.S. technology firm and is the world’s largest company in the communications equipment industry. Shares have seen significant underperformance compared to its

The Worst May Be Over for Cisco After Beating Estimates in Q4: https://www.marketbeat.com/logos/articles/med_20240816085900_the-worst-may-be-over-for-cisco-after-beating-esti.jpg
The Worst May Be Over for Cisco After Beating Estimates in Q4

Cisco Systems (NASDAQ: CSCO) is a U.S. technology firm and is the world’s largest company in the communications equipment industry. Shares have seen significant underperformance compared to its

Warren Buffett’s Recent Stock Moves: Top Buys and Sells to Watch: https://www.marketbeat.com/logos/articles/med_20240816101622_warren-buffetts-recent-stock-moves-top-buys-and-se.jpg
Warren Buffett’s Recent Stock Moves: Top Buys and Sells to Watch

As the second quarter comes to a wrap-up for the stock market, so do the required 13-F filings for some of Wall Street’s biggest investors. This time around, Warren Buffett’s report card came in

Lockheed Martin's Sky-High Surge: Buy Now or Wait for a Landing?: https://www.marketbeat.com/logos/articles/med_20240816084708_lockheed-martins-sky-high-surge-buy-now-or-wait-fo.jpg
Lockheed Martin's Sky-High Surge: Buy Now or Wait for a Landing?

Lockheed Martin (NYSE: LMT) has experienced a significant surge this year, climbing nearly 24% year-to-date and an impressive 20% this quarter alone, despite the broader market's recent pullback

Deere Rebounds on Earnings Beat, But Uphill Battle Remains: https://www.marketbeat.com/logos/articles/med_20240816083436_deere-rebounds-on-earnings-beat-but-uphill-battle.jpg
Deere Rebounds on Earnings Beat, But Uphill Battle Remains

Deere & Company (NYSE: DE) shares bounced upward by more than 6% following a better-than-expected fiscal third-quarter earnings report, although the company continues to face significant

3 Beaten-Down Tech Stocks That Shouldn’t Be Overlooked: https://www.marketbeat.com/logos/articles/med_20240815150405_3-beaten-down-tech-stocks-that-shouldnt-be-overloo.jpg
3 Beaten-Down Tech Stocks That Shouldn’t Be Overlooked

Equities are being whipsawed by conflicting economic data. Some data points support the soft-landing theory and would guide to lower interest rates. However, some data suggests that the economy is